Current Headlines

  1. Sartorius Stedim Biotech Launches Innovative ambr® 250 Modular Bioreactor System

    Sartorius Stedim Biotech (SSB) recently introduced the ambr® 250 modular, an innovative benchtop mini bioreactor system for parallel fermentation or cell culture. This system combines a unique single-use bioreactor vessel and expandable system design to offer bioprocess scientists access to advanced benchtop bioreactor technology for process development.

  2. Sartorius Stedim Biotech Presents Virosart® Media

    Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has launched Virosart® Media for virus retention in cell culture media.

  3. GE Healthcare Launches Next-Gen Biacore Molecular Interaction Analysis Platform

    GE Healthcare’s Life Sciences business recently launched the first of a next generation of Biacore systems harnessing Surface Plasmon Resonance (SPR) technology. Biacore 8K marks the start of a new generation of Biacore systems maintaining the high data quality expected from Biacore at high throughput.

  4. Bio-Rad Makes Purifying Proteins With NGC Chromatography Systems Even Easier

    Bio-Rad Laboratories, Inc. recently released ChromLab Software Version 4.0. When used with the NGC Chromatography System, the software version continues the ChromLab legacy of enabling researchers to purify their proteins with ease.

  5. Alvotech Opens State-Of-The-Art Biosimilar Facility In Iceland

    Alvotech, a powerful player in the field of biopharmaceuticals, recently announces the opening of a new state-of-the-art facility, dedicated to the development and manufacturing of biosimilar monoclonal antibodies (“mAbs”).

  6. PnuVax To Acquire Inactivated Yellow Fever Vaccine IP From GE Healthcare

    PnuVax Incorporated (PnuVax), a vaccine and biopharmaceutical company, and GE Healthcare’s Life Sciences business announced recently that they have entered an agreement under which PnuVax can acquire GE Healthcare’s intellectual property (IP) relating to an inactivated yellow fever vaccine.

  7. Accelovance Addresses CRA Shortage With Accelovance Academy Inaugural Graduation Class

    Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in vaccines, oncology, and general medicine clinical research held a graduation ceremony yesterday for Accelovance Academy's inaugural class of Clinical Research Associates (CRAs).

  8. Finesse SmartFactory Platform Featured New Manufacturing And Lab Facility In Iceland

    The first installation of Finesse’s new SmartFactory platform was featured when Alvotech announced the opening of its state-of-the-art manufacturing and lab facility in Reykjavik, Iceland.

  9. VWR Acquires JM Separations

    VWR (NASDAQ: VWR), the leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired JM Separations, B.V., a supplier of single-use fluid handling and separation technology products for pharmaceutical and biotech customers.

  10. FDA Grants Orphan Drug Designation To SUBA

    HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it has received notice of Orphan Drug Designation for treatment of patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS) with its oral formulation of SUBA-Itraconazole Capsules.